麻豆映画传媒官方app免费下载_国产狂喷潮在线播放_黄色美女性爱喷水视频网_男人的天堂免费观看视频_乱操av一区二区_亚洲黄色av一区_国产高清毛片视频在线播_久久调教亚洲精品

The abstract submission system will open in February 2026

Abstract submission deadlines

Abstract submission categories

• AI for diagnostics and profiling (pathology, radiology, molecular biology)
• AI for clinical workflows and decision-making
• AI for clinical research and drug development
• Basic science
• New diagnostic tools
• Pathology and molecular pathology
• Translational research and biomarkers
• Breast cancer, early stage
• Advanced breast cancer, other
• HER2+ breast cancer
• HR+ breast cancer
• Triple negative breast cancer
• CNS tumours
• Developmental therapeutics
• Biliary tract cancer, incl. cholangiocarcinoma
• Hepatocellular carcinoma (HCC)
• Oesophagogastric cancer
• Pancreatic cancer
• Colon cancer
• Rectal and anal cancer
• Germ cell (testicular) cancer and penile cancer
• Localised and locally advanced prostate cancer
• Metastatic prostate cancer
• Renal cancer
• Urothelial cancer
• Gynaecological cancers
• Haematological malignancies
• Head and neck cancer, excluding thyroid
• Investigational immunotherapy
• Melanoma
• Non-melanoma skin tumours
• Endocrine tumours
• Neuroendocrine tumours
• Thyroid cancer
• NSCLC, early stage
• NSCLC, locally advanced
• SCLC
• Thoracic malignancies, other
• NSCLC, metastatic
• Policy
• Sarcoma
• Early detection and intervention
• Primary prevention
• Secondary prevention
• Palliative care
• Psycho-oncology
• Supportive care
• Miscellaneous
• *Cancer Nursing: Digital innovation and technology in practice
• *Cancer Nursing: Equitable health care of underserved population
• *Cancer Nursing: Palliative and advanced cancer care across the cancer continuum
• *Cancer Nursing: Prevention, early detection and health promotion
• *Cancer Nursing: Supportive care and symptom management
• *Cancer Nursing: Workforce development for the future

*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO Congress 2026 submission regulations and guidelines.

Late-breaking abstracts (LBAs)

Late-breaking abstracts may be submitted for high quality, new research findings from prospective interventional clinical trials or observational series (large real world data sets) or novel technologies with major implications for clinical practice and/or understanding and targeting of disease processes.?

The final late-breaking abstract deadline of 8 September 2026 is?under no circumstances?to be considered as an extension of the general submission deadline.

Presentation and publication of accepted abstracts

The ESMO Congress 2026 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Presidential Symposium?– Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
• Proffered Paper?– Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Rapid Oral?– Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster?– Paper poster presentation for review and discussion onsite. Presenting authors must attend the Congress in person to represent their work. Preparation of an e-Poster file is also mandatory for inclusion in the Congress Virtual Platform and onsite digital screens.
• E-Poster?– Electronic poster in PDF format for inclusion in the Congress Virtual Platform and onsite digital screens. Presenting authors of ePosters are not required to attend the Congress in person to represent their work. Paper posters are?not to be prepared, and poster boards will not be provided.

All accepted abstracts, will be published online in the ESMO Congress 2026 Abstract Book, a supplement to the official ESMO journal,?Annals of Oncology.

ESMO Merit Award

A restricted number of ESMO Merit Awards for the ESMO Congress 2026 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition.

Candidates must be?ESMO Members under the age of 40?and indicate that they wish to be considered for a Merit Award at the time of submitting the abstract.
The selection will be made by the Scientific Committee on a competitive basis considering the scientific merit of the abstract.

Registration includes:

• Participation in scientific and educational sessions
• Opportunities to network with speakers, faculty and peers
• Access to the poster and e-Poster area
• Interaction with the industry partners in the exhibition area
• Participation in the Industry Satellite Symposia
• Live-streamed sessions and sessions on-demand on the virtual congress platform
• Access to the?meeting resources on OncologyPRO?after the event
• The?ESMO Daily Reporter

Registration fees and deadlines

Individual registration will remain open for the duration of the Congress. The ESMO Congress
Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.
ESMO membership must be?active ten (10) working days?prior to the relative registration, to be eligible for the reduced member registration fee. Please visit the?membership page on esmo.org?to check eligibility criteria, benefits, and to complete the membership application.

Please send an email to?registration@esmo.org?to request one of the badges in the "Other registration fees" table above. Kindly note, access to the sessions, virtual congress platform and webcasts are?not?included.